1. Home
  2. IMRN vs LOBO Comparison

IMRN vs LOBO Comparison

Compare IMRN & LOBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • LOBO
  • Stock Information
  • Founded
  • IMRN 1994
  • LOBO 2014
  • Country
  • IMRN Australia
  • LOBO China
  • Employees
  • IMRN N/A
  • LOBO N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • LOBO
  • Sector
  • IMRN Health Care
  • LOBO
  • Exchange
  • IMRN Nasdaq
  • LOBO NYSE
  • Market Cap
  • IMRN 15.0M
  • LOBO 13.6M
  • IPO Year
  • IMRN N/A
  • LOBO 2024
  • Fundamental
  • Price
  • IMRN $1.90
  • LOBO $1.50
  • Analyst Decision
  • IMRN Strong Buy
  • LOBO
  • Analyst Count
  • IMRN 1
  • LOBO 0
  • Target Price
  • IMRN $5.00
  • LOBO N/A
  • AVG Volume (30 Days)
  • IMRN 4.7K
  • LOBO 9.5K
  • Earning Date
  • IMRN 03-03-2025
  • LOBO 03-25-2025
  • Dividend Yield
  • IMRN N/A
  • LOBO N/A
  • EPS Growth
  • IMRN N/A
  • LOBO N/A
  • EPS
  • IMRN N/A
  • LOBO 0.00
  • Revenue
  • IMRN $3,271,194.00
  • LOBO $19,469,766.00
  • Revenue This Year
  • IMRN N/A
  • LOBO $72.16
  • Revenue Next Year
  • IMRN N/A
  • LOBO $41.04
  • P/E Ratio
  • IMRN N/A
  • LOBO $1,391.04
  • Revenue Growth
  • IMRN 171.67
  • LOBO N/A
  • 52 Week Low
  • IMRN $1.65
  • LOBO $1.32
  • 52 Week High
  • IMRN $5.96
  • LOBO $4.70
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 43.76
  • LOBO N/A
  • Support Level
  • IMRN $1.89
  • LOBO N/A
  • Resistance Level
  • IMRN $2.05
  • LOBO N/A
  • Average True Range (ATR)
  • IMRN 0.08
  • LOBO 0.00
  • MACD
  • IMRN -0.02
  • LOBO 0.00
  • Stochastic Oscillator
  • IMRN 3.85
  • LOBO 0.00

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About LOBO LOBO EV TECHNOLOGIES LTD

Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.

Share on Social Networks: